Alkeus Pharmaceuticals is a biopharmaceutical company focused on discovering and developing treatments against serious and untreatable diseases of the eye. Its lead program is based on molecules to address aging of the eye (dry age-related macular degeneration, also known as dry-AMD) and premature aging of the eye due to a genetic condition called Stargardt disease.